伟思医疗: directors' dealings · France · AMF SSE:688580 FR FR · AMF Mcap 4.6Bn€
Explore the full insider trade history of 伟思医疗, a publicly traded company based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €4.6bn. The latest transaction was filed on 5 January 2026 — Sale. Among the most active insiders: 高飞. The full history is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 462.7 M€
Gross profit 306.3 M€ 66% margin
Net income 138.1 M€ 29.8% margin
Balance sheet & cash
Market cap 4.64 Bn€
Total debt 1.1 M€
Free Cash Flow 58.6 M€
Last declaration on 5 January 2026
Declarations 9 total
Executives ● Sale18 SSE
5,771 shares
SSE:273000000089881060 · 5 Jan 2026
Executives ● Purchase2 SSE
2,500 shares
SSE:173000009804795260 · 19 Nov 2025
Ideal exit: 16 Aug 2026 (T+270) Executives ● Purchase2 SSE
1,632 shares
SSE:173000009618407420 · 30 Sept 2025
Ideal exit: 27 Jun 2026 (T+270) Executives ● Sale7 SSE
3,200 shares
SSE:173000009336901540 · 7 Aug 2025
Executives ● Sale11 SSE
12,000 shares
SSE:173000009021388900 · 5 Jun 2025
Executives ● Sale11 SSE
3,000 shares
SSE:173000009021388640 · 4 Jun 2025
Executives ● Sale11 SSE
5,000 shares
SSE:173000006526018720 · 26 Apr 2023
Executives ● Sale11 SSE
3,125 shares
SSE:173000006526018750 · 26 Apr 2023
Executives ● Sale2 SSE
3,125 shares
SSE:173000006252881100 · 2 Feb 2023